Health Care & Life Sciences » Pharmaceuticals | Extrawell Pharmaceutical Holdings Ltd.

Extrawell Pharmaceutical Holdings Ltd. | Income Statement

Fiscal year is April-March. All values HKD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
150,673.00
128,833.00
142,201.00
107,903.00
85,762.00
89,218
Cost of Goods Sold (COGS) incl. D&A
76,706.00
77,776.00
72,888.00
65,174.00
44,893.00
39,618
Gross Income
73,967.00
51,057.00
69,313.00
42,729.00
40,869.00
49,600
SG&A Expense
83,477.00
80,055.00
79,448.00
62,134.00
57,813.00
66,766
EBIT
-
28,998.00
10,135.00
19,212.00
16,944.00
17,166
Unusual Expense
10,747.00
58,218.00
23,953.00
33,397.00
37,735.00
79,850
Non Operating Income/Expense
57,923.00
638.00
1,226.00
2,864.00
60.00
793
Interest Expense
2,424.00
3,938.00
4,688.00
5,552.00
6,590.00
7,823
Pretax Income
37,349.00
52,146.00
27,490.00
18,927.00
29,186.00
63,374
Income Tax
20,574.00
92.00
90.00
616.00
86.00
50
Consolidated Net Income
16,775.00
52,238.00
27,400.00
18,311.00
29,272.00
63,324
Net Income
14,123.00
44,188.00
32,781.00
20,796.00
29,930.00
64,030
Net Income After Extraordinaries
14,430.00
653,833.00
32,781.00
20,796.00
29,930.00
64,030
Net Income Available to Common
13,816.00
46,410.00
32,781.00
20,796.00
29,930.00
64,030
EPS (Basic)
0.01
0.24
0.01
0.01
0.01
0.03
Basic Shares Outstanding
2,355,479.50
2,390,000.00
2,390,000.00
2,390,000.00
2,390,000.00
2,390,000
EPS (Diluted)
0.00
0.24
0.01
0.01
0.01
0.02
Diluted Shares Outstanding
3,007,800.50
2,390,000.00
3,290,000.00
3,290,000.00
3,290,000.00
3,290,000
EBITDA
6,570.00
22,969.00
3,841.00
12,785.00
10,617.00
10,929
Other Operating Expense
-
-
-
193.00
-
-
Non-Operating Interest Income
2,107.00
39,904.00
66,640.00
77,121.00
90,342.00
9,957
Minority Interest Expense
2,652.00
8,050.00
5,381.00
2,485.00
658.00
706
Equity in Affiliates (Pretax)
-
1,534.00
1,600.00
2,897.00
1.00
908

About Extrawell Pharmaceutical Holdings

View Profile
Address
Suites 2206-08, 22/F
Hong Kong
Hong Kong
Employees -
Website http://www.extrawell.com.hk
Updated 07/08/2019
Extrawell Pharmaceutical Holdings Ltd. engages in the marketing and distribution of pharmaceutical products. It operates through the following segments: Manufacturing, Trading, and Gene Development. The Manufacturing segment includes the development, manufacture, and sale of pharmaceutical products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.